Mitchell Kaufman, MD
Neurology · Little Rock, ARNPI 1164536553
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,800 and has fallen 88.2% since, to $212 in 2025.
Across 155 payments — averaging $33.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$1K
- Teva Pharmaceuticals USA, Inc.$500
- AstraZeneca$315
- Novartis$307
- Neurocrine Biosciences, Inc.$257
- EMD Serono, Inc.$255
- plus $2K from 32 others
What the payments were for
- Food & beverage$5,228100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 42 | $1,216 |
| Teva Pharmaceuticals USA, Inc. | 10 | $500 |
| AstraZeneca | 5 | $315 |
| Novartis | 8 | $307 |
| Neurocrine Biosciences, Inc. | 5 | $257 |
| EMD Serono, Inc. | 4 | $255 |
| Lundbeck LLC | 7 | $223 |
| Johnson & Johnson | 5 | $185 |
| Jazz Pharmaceuticals Inc. | 8 | $183 |
| Eisai Inc. | 6 | $176 |
| Sunovion Pharmaceuticals Inc. | 10 | $169 |
| Acorda Therapeutics, Inc | 8 | $143 |
| Amneal Pharmaceuticals LLC | 2 | $143 |
| SK Life Science, Inc. | 1 | $125 |
| Amgen | 1 | $125 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Neurelis, Inc. | 2 | $122 |
| Sanofi | 1 | $80 |
| Harmony Biosciences LLC | 2 | $70 |
| Kyowa Kirin, Inc. | 1 | $67 |
| AbbVie | 3 | $58 |
| Merz Pharmaceuticals, LLC | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| UCB, Inc. | 2 | $38 |
| Argenx US, Inc. | 1 | $30 |
| Scilex Pharmaceuticals Inc. | 2 | $29 |
| Adamas Pharmaceuticals, Inc. | 2 | $27 |
| Tanabe Pharma America, Inc. | 1 | $21 |
| Banner Life Sciences, LLC | 1 | $19 |
| Catalyst Pharmaceuticals, Inc. | 1 | $17 |
| CSL Behring | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Ipsen Biopharmaceuticals, Inc | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
| Boston Scientific | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
| Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,228 in reported general payments places this provider in the 60th percentile of 93 neurology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Little Rock
- Shitiz SriwastavaLittle Rock$59K
- Elizabeth SullivanLittle Rock$33K
- Kapil AryaLittle Rock$16K
- Robert SilzerLittle Rock$14K
- Bradley BoopLittle Rock$13K
- Duane BirkyLittle Rock$12K
- Abdel Rahman SalehLittle Rock$10K
- John IronsideLittle Rock$10K
- Christopher WrightLittle Rock$9K
- Srilatha ThadurLittle Rock$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.